PDF(Pubmed)
Abstract：
UNASSIGNED: Although cervical cancer is the most prevalent cancer in women and has a high morbidity, mortality, and low quality of life burden among human immune virus-positive women, there is little evidence of it in northeastern Ethiopia.
UNASSIGNED: Sought to determine the magnitude and associated factors of cervical cancer screening among human immune virus-positive women in public health facilities in northeastern Ethiopia.
UNASSIGNED: A multicentered, institution-based cross-sectional study with 401 participants using the systematic random sampling technique was employed. The data was gathered through personal interviews and chart reviews. The predictors were established via multivariate logistic regression analysis.
UNASSIGNED: The magnitude of cervical cancer screening was 19.2% (15.7%-22.9%). Multiparity, bad obstetric history, hearing about cervical cancer, recommendations from medical professionals, duration of antiretroviral therapy >10 years, a family record of cervical cancer, and knowing cervical cancer were revealed to be predictors of testing for cervical cancer.
UNASSIGNED: The magnitude of cervical cancer screening was 19.2% (15.7%-22.9%). Multiparity, bad obstetric history, hearing about cervical cancer, recommendations from medical professionals, duration of antiretroviral therapy >10 years, a family record of cervical cancer, and knowing cervical cancer were revealed to be predictors of testing for cervical cancer.
UNASSIGNED: Sought to determine the magnitude and associated factors of cervical cancer screening among human immune virus-positive women in public health facilities in northeastern Ethiopia.
UNASSIGNED: A multicentered, institution-based cross-sectional study with 401 participants using the systematic random sampling technique was employed. The data was gathered through personal interviews and chart reviews. The predictors were established via multivariate logistic regression analysis.
UNASSIGNED: The magnitude of cervical cancer screening was 19.2% (15.7%-22.9%). Multiparity, bad obstetric history, hearing about cervical cancer, recommendations from medical professionals, duration of antiretroviral therapy >10 years, a family record of cervical cancer, and knowing cervical cancer were revealed to be predictors of testing for cervical cancer.
UNASSIGNED: The magnitude of cervical cancer screening was 19.2% (15.7%-22.9%). Multiparity, bad obstetric history, hearing about cervical cancer, recommendations from medical professionals, duration of antiretroviral therapy >10 years, a family record of cervical cancer, and knowing cervical cancer were revealed to be predictors of testing for cervical cancer.
摘要：
尽管宫颈癌是女性中最常见的癌症，而且发病率很高，死亡率,人类免疫病毒阳性妇女的生活负担质量低，在埃塞俄比亚东北部几乎没有证据.
■旨在确定埃塞俄比亚东北部公共卫生机构中人类免疫病毒阳性妇女宫颈癌筛查的程度和相关因素。
■多输入，采用基于机构的横断面研究,采用系统随机抽样技术,对401名参与者进行研究.数据是通过个人访谈和图表审查收集的。通过多因素logistic回归分析建立预测因子。
■宫颈癌筛查的程度为19.2%（15.7%-22.9%）。多重奇偶校验，不良产科史,听说宫颈癌，医疗专业人士的建议，抗逆转录病毒治疗的持续时间>10年，宫颈癌的家族记录,并且知道宫颈癌是宫颈癌检测的预测因子。
■宫颈癌筛查的程度为19.2%（15.7%-22.9%）。多重奇偶校验，不良产科史,听说宫颈癌，医疗专业人士的建议，抗逆转录病毒治疗的持续时间>10年，宫颈癌的家族记录,并且知道宫颈癌是宫颈癌检测的预测因子。
■旨在确定埃塞俄比亚东北部公共卫生机构中人类免疫病毒阳性妇女宫颈癌筛查的程度和相关因素。
■多输入，采用基于机构的横断面研究,采用系统随机抽样技术,对401名参与者进行研究.数据是通过个人访谈和图表审查收集的。通过多因素logistic回归分析建立预测因子。
■宫颈癌筛查的程度为19.2%（15.7%-22.9%）。多重奇偶校验，不良产科史,听说宫颈癌，医疗专业人士的建议，抗逆转录病毒治疗的持续时间>10年，宫颈癌的家族记录,并且知道宫颈癌是宫颈癌检测的预测因子。
■宫颈癌筛查的程度为19.2%（15.7%-22.9%）。多重奇偶校验，不良产科史,听说宫颈癌，医疗专业人士的建议，抗逆转录病毒治疗的持续时间>10年，宫颈癌的家族记录,并且知道宫颈癌是宫颈癌检测的预测因子。
